Kazuhiro Sase (@ksase) 's Twitter Profile
Kazuhiro Sase

@ksase

Cardio-Oncology. Clinical Pharmacology and Regulatory Science. US-Japan HBD. JOCS. JSTAR. Sarcoma Awareness.

ID: 76813200

calendar_today24-09-2009 01:05:22

3,3K Tweet

532 Followers

1,1K Following

International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

🚨BREAKING NEWS FROM SOUTH AFRICA 🚨 The locations for #GCOS 2026 and 2027 have been announced! In 2026, we'll be back in the USA 🇺🇸 in historic Williamsburg, Virginia. Then, in 2027, we'll be having our first GCOS in Japan 🇯🇵. Visit our new GCOS Site: gcos.ic-os.org

🚨BREAKING NEWS FROM SOUTH AFRICA 🚨

The locations for #GCOS 2026 and 2027 have been announced!

In 2026, we'll be back in the USA 🇺🇸 in historic Williamsburg, Virginia. Then, in 2027, we'll be having our first GCOS in Japan 🇯🇵.

Visit our new GCOS Site: gcos.ic-os.org
Novi Yanti Sari (@slumberbell) 's Twitter Profile Photo

A milestone at #GCOS2025 ✨the first International Cardio-Oncology Society × European Society of Cardiology #ESCardioOnco joint session Today’s discussion brought together global expertise to move from guidelines to real-world practice, address challenges across diverse settings, & ensure patients benefit from evidence-based

A milestone at #GCOS2025 ✨the first <a href="/icosociety/">International Cardio-Oncology Society</a> × <a href="/escardio/">European Society of Cardiology</a> #ESCardioOnco joint session

Today’s discussion brought together global expertise to move from guidelines to real-world practice, address challenges across diverse settings, &amp; ensure patients benefit from evidence-based
International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

🚨 LEADERSHIP ANNOUNCEMENT 🚨 As announced at #GCOS25, Susan Dent (Susan dent) will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley (Mike Fradley, MD) taking over the role starting in 2026. #ThankYouDrDent #cardioonc

🚨 LEADERSHIP ANNOUNCEMENT 🚨

As announced at #GCOS25, Susan Dent (<a href="/sdent_cardioonc/">Susan dent</a>) will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley (<a href="/Dr_Mike_Fradley/">Mike Fradley, MD</a>)  taking over the role starting in 2026.

#ThankYouDrDent #cardioonc
NEJM (@nejm) 's Twitter Profile Photo

Presented at #KidneyWk: In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results:

Presented at #KidneyWk: 

In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results:
International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

To cap off our recap week of #GCOS2025, we look forward to the future: The next (2!) locations have been announced for #GCOS: 🇺🇸 #GCOS26 in Williamsburg, Virginia, USA 🇯🇵 #GCOS27 in Tokyo, Japan Once again, thanks for a great summit and we'll see you all next year! Stay

To cap off our recap week of #GCOS2025, we look forward to the future: The next (2!) locations have been announced for #GCOS:

🇺🇸 #GCOS26 in Williamsburg, Virginia, USA
🇯🇵 #GCOS27 in Tokyo, Japan

Once again, thanks for a great summit and we'll see you all next year!

Stay
Yuichi Tamura/ 田村雄一:心臓/循環器の学際領域のひと (@tamcardio) 's Twitter Profile Photo

肺動脈性肺高血圧症に対する新たなAIを活用した治療アプローチであるSATISFY JP試験の結果をAHA Late breakingで発表! IL6受容体抗体のサトラリズマブ投与をするPhase2試験で、治療反応性が期待できる内容は会場から大反響でした✨ #AHA25

肺動脈性肺高血圧症に対する新たなAIを活用した治療アプローチであるSATISFY JP試験の結果をAHA Late breakingで発表!
IL6受容体抗体のサトラリズマブ投与をするPhase2試験で、治療反応性が期待できる内容は会場から大反響でした✨
#AHA25
Yuichi Tamura/ 田村雄一:心臓/循環器の学際領域のひと (@tamcardio) 's Twitter Profile Photo

🚀 Presented the SATISFY-JP trial at #AHA25 Late-Breaking! A new AI-driven precision approach for pulmonary arterial hypertension using the IL-6 receptor antibody satralizumab (Phase II) showed promising treatment responsiveness — sparking major excitement in the audience! ✨

🚀 Presented the SATISFY-JP trial at #AHA25 Late-Breaking!
A new AI-driven precision approach for pulmonary arterial hypertension using the IL-6 receptor antibody satralizumab (Phase II) showed promising treatment responsiveness — sparking major excitement in the audience! ✨
Diego Sadler MD FACC (@dsadlermd) 's Twitter Profile Photo

Epic debate on use of ICIs on heart transplant recipients: challenges, need for more data and two very talented and entertaining debaters! #AHA2025 Richardkcheng Eric H Yang, MD

Epic debate on use of ICIs on heart transplant recipients: challenges, need for more data and two very talented and entertaining debaters! #AHA2025 <a href="/Richardkcheng2/">Richardkcheng</a> <a href="/datsunian/">Eric H Yang, MD</a>
Ana Barac, MD, PhD, FACC, FAHA (@anabaraccardio) 's Twitter Profile Photo

What connects MRAs, dexrazoxane, iv iron & immune checkpoint inhibitors? hard clinical questions!! Kudos to AHA Science on charting the #HF & #CardioOnc collaboration in clinical practice through fun debates! #AHA25 Dipti Gupta MD, MPH Eric H Yang, MD Richardkcheng

What connects MRAs, dexrazoxane, iv iron  &amp; immune checkpoint inhibitors? hard clinical questions!! Kudos to    <a href="/AHAScience/">AHA Science</a> on charting the #HF &amp; #CardioOnc collaboration in clinical practice through fun debates! #AHA25 <a href="/DrGuptaD/">Dipti Gupta MD, MPH</a> <a href="/datsunian/">Eric H Yang, MD</a> <a href="/Richardkcheng2/">Richardkcheng</a>
日本循環器学会 情報広報部会 (@jcirc_ipr) 's Twitter Profile Photo

AHA2025の会期中に、Leadership Meetingを開催されました✨ 次回のMOU継続更新や新しいコラボレーションについてディスカッションが行われました📢 AHAの皆様は次回JCSにも参加予定で、Joint Symposium他、新な企画を準備中です! 続報をお楽しみに☝️ #AHA2025 #JCS #Collaboration #Cardiology

AHA2025の会期中に、Leadership Meetingを開催されました✨
次回のMOU継続更新や新しいコラボレーションについてディスカッションが行われました📢
AHAの皆様は次回JCSにも参加予定で、Joint Symposium他、新な企画を準備中です!
続報をお楽しみに☝️
#AHA2025 #JCS #Collaboration #Cardiology